Terms: = Pancreatic cancer AND PTPRB, ENSG00000127329, 5787, MGC142023, DKFZp686H15164, MGC59935, PTPB, HPTP-BETA, P23467, HPTPB, R-PTP-BETA, FLJ44133, DKFZp686E2262
4 results:
1. PSMD11, PTPRM and ptprb as novel biomarkers of pancreatic cancer progression.
Sahni S; Krisp C; Molloy MP; Nahm C; Maloney S; Gillson J; Gill AJ; Samra J; Mittal A
Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129682. PubMed ID: 32663515
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of resection of the papilla of Vater for the treatment of cancer in the papilla of Vater.
Kinoshita H; Hara M; Nishimura K; Kodama T; Matsuo H; Kawahara R; Yasunaga M; Sakai H; Odo M; Okuda K; Shirouzu K; Aoyagi S
Kurume Med J; 2003; 50(1-2):17-9. PubMed ID: 12971258
[TBL] [Abstract] [Full Text] [Related]
3. Molecular cloning of a human transmembrane-type protein tyrosine phosphatase and its expression in gastrointestinal cancers.
Matozaki T; Suzuki T; Uchida T; Inazawa J; Ariyama T; Matsuda K; Horita K; Noguchi H; Mizuno H; Sakamoto C
J Biol Chem; 1994 Jan; 269(3):2075-81. PubMed ID: 8294459
[TBL] [Abstract] [Full Text] [Related]
4. A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma.
Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
Eur J Gynaecol Oncol; 1990; 11(2):127-33. PubMed ID: 2379512
[TBL] [Abstract] [Full Text] [Related]
